POTENT AND SELECTIVE IRREVERSIBLE INHIBITORS OF IRAK1
摘要:
The disclosure relates to compounds that act as irreversible inhibitors interleukin 1 (IL-1) receptor-associated kinases (IRAKs); pharmaceutical compositions comprising the compounds; and methods of treating or preventing kinase-mediated disorders, including cancer and other proliferation diseases.
信息查询
0/0